| 000 | 01119 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516233640.0 | ||
| 264 | 0 | _c20150130 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/clpt.2014.191 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeldman, A M | |
| 245 | 0 | 0 |
_aResponse to "clarification of enrolled subjects in tolvaptan HF trials". _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cDec 2014 |
||
| 300 |
_a661 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntidiuretic Hormone Receptor Antagonists |
| 650 | 0 | 4 |
_aArginine Vasopressin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aHamad, E | |
| 700 | 1 | _aTsai, E | |
| 700 | 1 | _aZhu, W | |
| 700 | 1 | _aTilley, D G | |
| 700 | 1 | _aAlvarez, R | |
| 700 | 1 | _aCheung, J Y | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 96 _gno. 6 _gp. 661 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2014.191 _zAvailable from publisher's website |
| 999 |
_c24201503 _d24201503 |
||